Prostate cancer treatment regret is 52 percent higher in men with cardiovascular disease
Prostate cancer patients with cardiovascular disease were 52 per cent more likely to regret their treatment choices than men without problems with their heart or veins, according to a study published in the July issue of the urology journal BJUI International.
Research led by Harvard Medical School, USA, looked at 795 men with recurrent cancer in the Comprehensive Observational Multicenter Prostate Adenocarcinoma (COMPARE) registry.
"Treatment regret can have an adverse impact on a patient's overall outlook and has been associated with a poorer global quality of life" ...